La descarga está en progreso. Por favor, espere

La descarga está en progreso. Por favor, espere

Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT? by Juan Carlos Caballero, Mercedes Sánchez-Barba,

Presentaciones similares


Presentación del tema: "Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT? by Juan Carlos Caballero, Mercedes Sánchez-Barba,"— Transcripción de la presentación:

1 Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT? by Juan Carlos Caballero, Mercedes Sánchez-Barba, Mónica Del Rey, Kamila Janusz, Eva Lumbreras, María Abáigar, Robledo Cristina, Andrés Jerez, Esperanza Such, Guillermo Sanz, Cristina Calderon, David Valcarcel, Jesus Maria Hernandez- Rivas, María Consuelo Cañizo, and María Díez-Campelo Blood Volume 126(23):2890-2890 December 3, 2015 ©2015 by American Society of Hematology

2 Juan Carlos Caballero et al. Blood 2015;126:2890 ©2015 by American Society of Hematology

3 Juan Carlos Caballero et al. Blood 2015;126:2890 ©2015 by American Society of Hematology

4 Juan Carlos Caballero et al. Blood 2015;126:2890 ©2015 by American Society of Hematology


Descargar ppt "Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT? by Juan Carlos Caballero, Mercedes Sánchez-Barba,"

Presentaciones similares


Anuncios Google